Status:
COMPLETED
Validation of a Remediation Method for Memory Disorders Using Motor and Emotional Encoding in Patients With Alzheimer's Disease
Lead Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Conditions:
Alzheimer Disease
Eligibility:
All Genders
60-90 years
Phase:
NA
Brief Summary
Memories are more robust when they are multitraced. This means that the more a piece of information is mediated by different sensory inputs, the more resistant it is to being forgotten. Many works in ...
Detailed Description
In a within subjects design, all patients take part in four conditions. In each condition, sentences describing actions will be displayed. In a control condition, they will be asked to read the senten...
Eligibility Criteria
Inclusion
- Diagnosis of Alzheimer's disease by one of the consulting physicians, neurologist and/or geriatrician of whom the patient has been informed.
- Early stage (MMSE ≥ 22)
- Neuropsychological assessment within 6 months of inclusion.
- Affiliation with a social security scheme
- Age equal to or greater than 60
- French mother tongue
- Agreement to participate / signature of consent form
Exclusion
- Uncorrected perceptual disorders
- Other neurological or psychiatric history
- Inability to communicate
- Delusional or psychotic state
- Person unable to give informed consent
- Refusal to participate
- Participation in a study on a drug/medical device/care technique likely to affect cognitive functions
Key Trial Info
Start Date :
January 22 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 16 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06105047
Start Date
January 22 2024
End Date
May 16 2025
Last Update
June 25 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Grenoble
Grenoble, France
2
CHU de Saint-Etienne
Saint-Etienne, France, 42055
3
HCL
Villeurbanne, France